Biomea Fusion Inc is a preclinical-stage biopharmaceutical company. It is focused on the discovery, development and commercialization of irreversible small molecule drugs to treat patients with genetically defined cancers. The companies lead product candidate, BMF-219, is designed to be an orally bioavailable, potent and selective irreversible inhibitor of menin, an important transcriptional regulator known to play a direct role in oncogenic signaling in multiple cancers.

Earnings

see more
Q2 2021Est.ActualSurprise
EPS
(EXPECTED)2021-08-03
REV
Q1 2021Est.ActualSurprise
EPS
(EXPECTED)2021-05-21
REV

Related Companies

TickerCompanyChg %Mkt Cap
BMEABiomea Fusion-0.82%

Biomea Fusion Company Questions & Answers

Q

How do I buy Biomea Fusion (BMEA) stock?

A

You can purchase shares of Biomea Fusion (NASDAQ: BMEA) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Biomea Fusion's (BMEA) main competitors?

A

There are no as such competitors for Biomea Fusion.

Q

What is the target price for Biomea Fusion?

A

There is no analysis for Biomea Fusion

Q

How much is Biomea Fusion (BMEA) stock ?

A

The stock price for Biomea Fusion (NASDAQ: BMEA) is $16.94 last updated Fri May 07 2021 20:00:02 GMT+0000 (Coordinated Universal Time).

Q

When is the next Biomea Fusion (BMEA) dividend?

A

There are no upcoming dividends for Biomea Fusion.

Q

When is Biomea Fusion (NASDAQ:BMEA) reporting earnings?

A
Biomea Fusion’s Q2 earnings are confirmed from now on August 3, 2021.
Q

When is the upcoming split for BMEA?

A

There is no upcoming split for Biomea Fusion.